Uncovering the mode of action of engineered T cells in patient cancer organoidsJohanna F. Dekkers, Anne C. Rios, Sam de Blank et al.|Nature Biotechnology|2022Cited by 217
De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell functionNils Bessler, Anne C. Rios, Amber K. L. Wezenaar et al.|Nature Cancer|2026Cited by 8
IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline gliomaRaphaël Collot, Anne Rios, Cristian Ruiz-Moreno et al.|Cancer Cell|2026Cited by 3
Cancer-myeloid cell invasive program in pediatric-type diffuse high-grade gliomaCristian Ruiz Moreno, Hendrik G. Stunnenberg, Raphaël Collot et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0
TMOD-24. Modeling Pediatric DMG in Human BrOs (Brainstem-regionalized Organoids) Dissects Tumour–Microglia–Immune Crosstalk and CAR T Cell DysfunctionNils Bessler, Anne C. Rios, Amber K. L. Wezenaar et al.|Neuro-Oncology|2025Cited by 0